FactorPad
Build a Better Process

Stock Risk Measures for Seattle Genetics Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 28 for SGEN below.

/ factorpad.com / stocks / f22zrd.html


An ad-free and cookie-free webpage by FactorPad


SGEN Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Seattle Genetics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how SGEN stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f22zrd.html


SGEN stock risk
SEATTLE GENETICS INC stock beta
SGEN risk report
SGEN f22zrd
SGEN risk analysis
SGEN volatility
SEATTLE GENETICS INC credit risk
SGEN liquidity risk
SGEN leverage
SGEN valuation
SGEN systematic risk
SGEN specific risk
SEATTLE GENETICS INC volatility
SGEN analysis
SGEN financial ratio

This is a new resource, spread the word, tell a friend